Murae Organisor Ltd Board of Directors to consider and approve;

Bonus Issue and Declaration of dividend of up to 100% of the face value

• Company’s revenue and Net Profit Rise multi-fold; Revenue at Rs. Rs. 854.82 crore in FY 2025; Net Profit surges to Rs. 7.52 crore

• Company fix June 11 as the record date for 1:2 stock Split

Ahmedabad, June 3, 2025: Meeting of the Board of directors of Ahmedabad based Murae Organisor Ltd (BSE- 542724) – engaged in the pharmaceutical business, including the marketing, trading, and distribution of a diverse range of pharmaceutical products is scheduled to held on 13 June 2025 to consider and approve, bonus issue of equity shares to the shareholders of the company, subject to necessary approvals and compliances.

Board of directors also to consider and approve declaration of dividend of up to 100% of the face value of equity shares (Rs. 2 per share) of the Company for the financial year 2024-25, subject to shareholders’ approval, if applicable. Board of directors also propose to consider strategic business expansion proposals, including capital deployment for proposed and ongoing projects in the agro and distillery sectors.

Company has reported a Steller performance for the Q4 and FY 2025 ended March 2025. Company reported revenue from operations of Rs. 854.82 crore, over 336 times higher as compared to the revenue of Rs. 2.54 crore in FY 2024. Net profit for FY 2025 too surged to Rs. 7.52 crore as against net profit of Rs. 5.31 lakh in FY 2024. For Q4FY2025 company reported revenue from operations of Rs. 515.53 crore and Net profit of Rs. 2.85 crore. 

Board of directors of the company in the meeting has fixed 11 June 2025 as the record date for the purpose of determining the eligibility of shareholders for 1:2 stock split. Board of directors of the company in the meeting held on 30^th May 2025 has approved Sub-division (stock split) of every 1 equity share of face value of Rs. 2 each into 02 equity shares of face Value of Rs. 1 each. as approved by the shareholders through Postal Ballot on May 29, 2025.

Incorporated in 2012, Murae Organisor Limited is engaged in the pharmaceutical business, including the marketing, trading, and distribution of a diverse range of pharmaceutical products, such as antibiotics, anti-malarial drugs, and anti-allergic medications. The company offers a wide range of products across various segments, including antibiotics, anti-malarial, dermatology, neurological, steroids, gynecology, and injections.

In January 2025, company has successfully completed its Rs. 46.47 crore Rights Issue. Company issued 23.23 crore equity share at Rs. 2 per share. The Right issue had received overwhelming response and subscribed 1.40 times. Company plans to invest for the expansion purpose including working capital requirements and general corporate purposes.

Company is strategically expanding into the agro-industrial sector by planning to acquire agricultural land in Kutch, Gujarat. The proposed investment, estimated between Rs. 20 – 25 crore and aims to cultivate high-quality pomegranates and establish a state-of-the-art distillery facility on the acquired premises. This initiative is contingent upon thorough due diligence processes and the requisite regulatory approvals and statutory clearances. The company intends to leverage Kutch's favorable agro-climatic conditions for pomegranate cultivation, aligning with government schemes such as the National Horticulture Mission, Pradhan Mantri Krishi Sinchai Yojana (PMKSY), and the Gujarat Industrial Policy 2020. These policies support agricultural and industrial development through subsidies, tax benefits, and infrastructural assistance. The proposed investment is subject to due diligence, regulatory approvals, and statutory clearances.

Company also plans to enhance its operational capabilities by planning to establish a state-of-the-art distillery facility on the agricultural land it intends to acquire in Kutch, Gujarat. This strategic initiative aims to diversify the company's product offerings and strengthen its presence in the agro-industrial sector. By venturing into the production of value-added products, Murae Organisor seeks to tap into under-explored yet lucrative market segments, potentially leading to improved profit margins and sustainable long-term growth.

Disclaimer
The information provided in this media release is based on current facts and circumstances as of the date of publication. It may contain forward-looking statements, including but not limited to projections, expectations, or assumptions about future events or performance. These forward-looking statements are subject to risks, uncertainties, and other factors that may cause actual results to differ materially from those anticipated. Hester Biosciences Ltd does not undertake any obligation to update, revise, or correct any forward-looking statements based on new information or future events. This release is intended for informational purposes only and does not constitute financial, investment, or professional advice.